Since 1973, NFCR has provided more than $288 million to fund cancer research and prevention education. NFCR has allowed some of the world's brightest scientists to take initial steps toward breakthrough discoveries, laying the groundwork for the development of many of today's most innovative and effective cancer therapies.

Our efforts are paying off. In just the past year, NFCR scientists have achieved:

• 19 novel research tools and technologies. Development and optimization of these tools is critical for improving anticancer drug screening, drug delivery, drug manufacturing and clinical treatment.

• 7 cancer biomarkers. Identification and characterization of these genetic phenomena are shedding new light on cancer's vulnerabilities and leading doctors to developing new tools for early diagnosis and personalized treatment of each patient's cancer.

• 19 new drug candidates and potential cancer therapeutics. Identification of these anticancer agents could lead to new treatment options that are desperately needed by patients.

• 3 cancer preventative measures. Dietary nutrients, drug compounds, and a cancer risk prediction model were developed and evaluated for their potential to prevent lung, pancreatic, and other cancers.

• 18 cancer-related genes and proteins. Discovery and further exploration of these key cancer molecules could provide new targets for drug development.

• 10 clinical trials. New treatments and cancer diagnostics made possible by laboratory breakthroughs are now being further investigated in clinical trials, getting closer than ever to the patient bedside.

Click here to view a select list of research milestones from NFCR-supported scientists.